Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology
ISSN: 1665-2681

Annals of Hepatology (AoH) is an international, open access journal published bi-monthly with funds from the Fundación Clínica Médica Sur. It is the official journal of the Mexican Association of Hepatology (AMH), the Latin American Association for the Study of the Liver (ALEH), the Canadian Association for the Study of the Liver (CASL) and the Czech Society of Hepatology (CSH). AoH publishes editorials, opinions, concise reviews, original articles, brief reports, letters to the editor, news from affiliated associations, clinical practice guidelines and summaries of congresses in the field of Hepatology.

Topics covered by AoH include alcoholic liver disease, autoimmune hepatitis, biliary diseases, drug-induced liver injury, genetic liver diseases, NAFLD/NASH and viral hepatitis (HAV, HBV, HCV, HDV, HEV). Our journal seeks to publish articles on basic clinical care and translational research focused on preventing rather than treating the complications of end-stage liver disease.

See more Open Access

Indexed in:

Scopus, Web of Science, Medline/PubMed, DOAJ and Conacyt

See more

Follow us:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2021

See more
Impact factor 2021
3.388
Citescore

CiteScore measures average citations received per document published.

See more
Citescore 2021
4.7
SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more
SJR 2021
0.676
SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more
SNIP 2021
0.881
View more metrics
Hide
Articles in press

Articles in press are accepted, peer reviewed articles that are not yet assigned to volumes/issues, but are citable using DOI. More info

Late evening snack and oral amino acid capsules improved respiratory quotient and Fischer ratio in patients with alcoholic liver cirrhosis
Juan Zhao, Jing Wu, Juan Li, Zhong-Ying Wang, Qing-Hua Meng
Open access
Available online 26 September 2022
Body weight loss and glycemic control on the outcomes of patients with NAFLD. The role of new antidiabetic agents
Diego García-Compeán, Ramesh Kumar, Ángel Noe del Cueto-Aguilera, Héctor Jesús Maldonado-Garza, Jesús Zacarías Villarreal-Pérez
Open access
Available online 25 September 2022
Current approaches to hepatic encephalopathy
Norberto C. Chávez-Tapia, Paulina Vidal-Cevallos, Misael Uribe
Open access
Pre-proof. Available online 15 September 2022
View all Ahead of print
Current Issue
Issue
Vol. 27. Issue 5.
(September - October 2022)
Editorial board
Ann Hepatol. 2022;27:100754
Open access
Editorials
Challenges for hepatitis C in Mexico: a public health perspective towards 2030
Martha Carnalla, Sergio Bautista-Arredondo, Tonatiuh Barrientos-Gutiérrez
Ann Hepatol. 2022;27:100748
Open access
Opinions
The translational approach to liver transplantation
P. Constanza Arriola Benitez, M. Virginia Gentilini, Gabriel E. Gondolesi
Ann Hepatol. 2022;27:100747
Open access
Concise reviews
Possible roles of Golgi protein-73 in liver diseases
Meng-Yuan Liu, Lu Huang, Jiang-Feng Wu, Hong-Bing Zhang, Wen-Bing Ai, Rui-Tao Zhang
Ann Hepatol. 2022;27:100720
Open access
View all issue
Issues in progress
View all issues in progress
Archive
View all archive
Supplements
View all supplements
Special content about COVID-19
Antibody response after a booster dose of SARS-CoV-2 vaccine in liver transplant recipients and those with chronic liver diseases
Mahak Chauhan, Ihechiluru Nzeako, Feng Li, Paul J. Thuluvath
10.1016/j.aohep.2022.100702
Open access
Trends in drug prescriptions for type 2 diabetes, hypertension, and dyslipidemia among adults with non-alcoholic fatty liver disease
Toshiya Machida, Taku Obara, Makoto Miyazaki, Jun Inoue, Nariyasu Mano
10.1016/j.aohep.2022.100699
Open access
View all COVID-19 artciles
Most Often Read
Milestones
Andres Ruf, Melisa Dirchwolf, Richard B. Freeman
10.1016/j.aohep.2021.100535
Ann Hepatol. 2022;27:
This article has been read 1.916 times
View all Most Often read articles
Instructions for authors
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos